BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Business

  Former Roche Exec Joins NovImmune SA as New CEO

  December 21, 2015

   · 

  1 min read
• Drug Development

  Baxalta’s ADYNOVATE Meets Endpoints in Late-Stage Study

  December 21, 2015

   · 

  9 min read
• Business

  THERAVECTYS Taps Alain Clergeot as New CEO

  December 21, 2015

   · 

  1 min read
• Business

  Immunocore Raises $5 Million Series A Financing To Advance Novel Cancer Immunotherapies

  December 21, 2015

   · 

  3 min read
• Business

  Bayer, CRISPR Form $335 Million Gene Editing Venture

  December 21, 2015

   · 

  7 min read
• Biotech Bay

  CytomX Added to Russell 2000 Index

  December 21, 2015

   · 

  3 min read
• Business

  Guardant Health And Mirati Therapeutics Enter Into Collaboration On Glesatinib (MGCD265) In Non Small Cell Lung Cancer (NSCLC) Trial

  December 21, 2015

   · 

  7 min read
• HKSTP And GIBH Co-Organise Hong Kong & Guangzhou International Conference On Stem Cell & Regenerative Medicine

  December 21, 2015

   · 

  8 min read
• Business

  Recipharm AB Signs Manufacturing Agreement With Alcon And Acquires Facility In France, Adding New Niche Capabilities

  December 21, 2015

   · 

  1 min read
• Business

  Foundation Medicine, Inc. And Mirati Therapeutics Collaborate To Develop A Companion Diagnostic For Glesatinib (MGCD265) In Non-Small Cell Lung Cancer (NSCLC)

  December 21, 2015

   · 

  8 min read